Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc. (LYEL)

Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
14. 53
+0.21
+1.4316%
$
350.9M Market Cap
- P/E Ratio
- Div Yield
66,957 Volume
-0.85 Eps
$ 14.32
Previous Close
Investors:
Add Transaction
Day Range
14.01 14.84
Year Range
10.76 45
Want to track LYEL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Lyell Immunopharma, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
26,080 $611,229.94 $363,816 -$247,413.94 -40.48%
Joseph Castro
Joseph Castro Nuveen LLC
12,595 $160,586.25 $180,486.35 $19,900.1 12.39%
Jennifer Grunberg
Jennifer Grunberg Allspring Global Investments Holdings LLC
16,145 $205,848.75 $228,774.65 $22,925.9 11.14%
Li Peng
Li Peng China Universal Asset Management Co. Ltd.
3,714 $41,285.62 $48,059.16 $6,773.54 16.41%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
68 $867 $879.92 $12.92 1.49%
AA
Andrew Alkon EntryPoint Capital, LLC
19,410 $247,477.5 $275,039.7 $27,562.2 11.14%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
3,446 $43,936.5 $44,591.24 $654.74 1.49%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
452 $7,590.24 $6,648.92 -$941.32 -12.4%